ID   MOA2/CDDP
AC   CVCL_Y206
DR   Wikidata; Q54906289
RX   PubMed=2547517;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y205 ! MOA2
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 11
//
RX   PubMed=2547517;
RA   Hida T., Ueda R., Takahashi T., Watanabe H., Kato T., Suyama M.,
RA   Sugiura T., Ariyoshi Y., Takahashi T.;
RT   "Chemosensitivity and radiosensitivity of small cell lung cancer cell
RT   lines studied by a newly developed
RT   3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
RT   hybrid assay.";
RL   Cancer Res. 49:4785-4790(1989).
//